Skip to main content

Table 4 Number (percentage) of patients with adverse event in the study population

From: Can hybrid hyaluronic acid represent a valid approach to treat rizoarthrosis? A retrospective comparative study

  Sinovial H-L Group (n = 55) Triamcinolone Group (n = 45)
Joint pain 2 (3.63%) 2 (4.44%)
Joint swelling 0 (0%) 1 (2.22%)
Injection site haematoma 0 (0%) 1 (2.22%)
Total number of patients with adverse event 2 (3.63%) 4 (8.88%)